SINOMAB BIO-B (03681): Lai Weiqi Appointed as Company Secretary
Stock News
Oct 08
SINOMAB BIO-B (03681) announced that Zhou Yuyan has resigned from her position as company secretary, effective October 8, 2025. The board of directors also announced that Lai Weiqi has been appointed as company secretary to succeed Zhou Yuyan, effective October 8, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.